COMMUNIQUÉS West-GlobeNewswire

DBV Technologies publie ses résultats financiers du 1er trimestre 2026
30/04/2026
Châtillon, France, 30 avril 2026 DBV Technologies publie ses résultats financiers du 1er trimestre 2026 Trésorerie et équivalents de trésorerie de 229 millions de dollars au 31 mars 2026, portant l’horizon de trésorerie [...]
DBV Technologies Reports First Quarter 2026 Financial Results
30/04/2026
Châtillon, France, April 30, 2026 DBV Technologies Reports First Quarter 2026 Financial Results Reported cash and cash equivalents of $229 million as of March 31, 2026 —providing funding into the second quarter of 2027 [...]
Emergent BioSolutions Reports First Quarter 2026 Financial Results
30/04/2026
First Quarter 2026 Total Revenues of $156.1 million First Quarter 2026 Net Income of $6.8 million and Net Income Margin of 4% First Quarter 2026 Adjusted EBITDA of $35.6 million and Adjusted EBITDA Margin of 23% [...]
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
30/04/2026
MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced a [...]
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update
30/04/2026
VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7J0), a biopharmaceutical company advancing next-generation cancer therapies [...]
The Oaks Residence Announces Grand Opening and Open House
30/04/2026
Mississippi’s First and Only Boutique Luxury Assisted Living Residence Holds Grand Opening Event GLUCKSTADT, Miss., April 30, 2026 (GLOBE NEWSWIRE) -- The Oaks Residence , Mississippi’s first and only boutique luxury [...]
MyGriefAngels.org Launches "Grief @ Work Insights" Hub to Bridge the Support Gap in the Modern Workplace
30/04/2026
The groundbreaking free resource equips grieving employees and forward-thinking organizations worldwide with the policies, legislation, research, and compassionate guidance needed to navigate loss in the modern [...]
TLX101-Px (Pixlumi®) MAA Accepted in Europe
30/04/2026
MELBOURNE, Australia and INDIANAPOLIS, May 01, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the marketing authorization application (MAA) filed in Europe [...]
Leo International Precision Health AG Reports 2025 Results and Establishes Strategic Foundation for AI-Driven Precision Health Platform
30/04/2026
Planegg/Martinsried, Germany, April 30, 2026 – Leo International Precision Health AG (“LIPH” or the “Company”, ticker symbol: LEOW), a holding company building a global integrated AI-driven healthcare ecosystem, today [...]
FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update
30/04/2026
On track for first patient dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers in Q2 of 2026 HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a [...]
Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results
30/04/2026
Press Release – No. 8 / 2026 Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results Copenhagen, Denmark and Boston, Massachusetts, April 30, 2026 – Zealand Pharma A/S [...]
Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554
30/04/2026
Ghent, Belgium – April 30, 2026 – Confo Therapeutics , a leader in the development of medicines targeting G-protein coupled receptors (GPCRs), today announced that the first patients were dosed in a Phase 2a clinical [...]
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
30/04/2026
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Dijon, France le 30 avril 2026 (17h45 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ) , société pharmaceutique spécialisée en phase avancée de développement et [...]
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
30/04/2026
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Dijon, France le 30 avril 2026 (17h45 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ) , société pharmaceutique spécialisée en phase avancée de développement et [...]
Disclosure of transparency notification from BlackRock, Inc.
30/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 30 April 2026 – 6 PM CET Disclosure of transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of [...]
SPINEWAY :
30/04/2026
Ecully, le 30 avril 2026 – 18h00 Chiffre d’affaires du 1er trimestre 2026 Niveau de commandes élevé Normalisation plus lente que prévue des approvisionnements 2026 : trajectoire de croissance confirmé En milliers d’ [...]
Spineway : First-quarter 2026 revenue
30/04/2026
Ecully, April 30, 2026 – 6:00 p.m. First-quarter 2026 revenue High order volume Slower-than-expected normalization of supply chains 2026: growth trajectory confirmed In thousands of euros 2026 2025 Change as a % Q1 [...]
KAI Conversations Announces Strategic Partnership with Syneos Health to Advance U.S. Pharmaceutical Commercialization
30/04/2026
AI-Driven Field Insights Drive Pharmaceutical Brand Performance in World’s Largest Market LONDON, April 30, 2026 (GLOBE NEWSWIRE) -- KAI Conversations, an AI-powered conversation intelligence platform purpose-built for [...]
Ocubio Announces Appointment of Jim Mazzo and Dr. Eric Donnenfeld as Strategic Advisors
30/04/2026
MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- Ocubio, a biotechnology company advancing personalized, biologic-based therapies for ocular surface disease, today announced the appointment of James V. Mazzo and Eric D. [...]

Pages